TY  - JOUR
AU  - Guerrouahen, Bella
AU  - Elnaggar, Muhammad
AU  - Al-Mohannadi, Anjud
AU  - Kizhakayil, Dhanya
AU  - Bonini, Chiara
AU  - Benjamin, Reuben
AU  - Brentjens, Renier
AU  - Buchholz, Christian J
AU  - Casorati, Giulia
AU  - Ferrone, Soldano
AU  - Locke, Frederick L
AU  - Martin, Francisco
AU  - Schambach, Axel
AU  - Turtle, Cameron
AU  - Veys, Paul
AU  - van der Vliet, Hans J
AU  - Maccalli, Cristina
AU  - EICCI Faculty Group
PY  - 2021
DO  - 10.3389/fimmu.2020.589381
UR  - http://hdl.handle.net/10668/17178
T2  - Frontiers in immunology
AB  - The progress in the isolation and characterization of tumor antigen (TA)-specific T lymphocytes and in the genetic modification of immune cells allowed the clinical development of adoptive cell therapy (ACT). Several clinical studies highlighted the...
LA  - en
KW  - CAR-NK cells
KW  - CAR-T cells
KW  - TCR engineered lymphocytes
KW  - cancer
KW  - clinical trial
KW  - immunotherapy
KW  - monoclonal antibody
KW  - off-the-shelf development
KW  - Animals
KW  - Genetic Engineering
KW  - Humans
KW  - Immunotherapy
KW  - Immunotherapy, Adoptive
KW  - Neoplasms
KW  - Qatar
KW  - Receptors, Chimeric Antigen
KW  - T-Lymphocytes
TI  - Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.
TY  - research article
VL  - 11
ER  -